Company News for Dec 4, 2019

Zacks Equity Research Published on December 04, 2019

UnitedHealth Group Inc.’s (UNH - Free Report) shares fell 1% after the company declared that its full year 2020 adjusted earnings per share will be in the range of $16.25-$16.55. Its mid-point of $16.40 lagged the current Zacks Consensus Estimate of $16.44.
PepsiCo Inc. (PEP - Free Report) dropped 0.3% after the company decided to acquire BFY Brands Inc. for an undisclosed sum.
Shares of Cleveland-Cliffs Inc. (CLF - Free Report) plunged 10.7% following its decision to acquire AK Steel Holding Corp. for a consideration of $1.1 billion in an all-stock deal.
Audentes Therapeutics Inc. jumped 106% following news that Japan’s Astellas Pharma Inc. will acquire the company for a consideration of $3 billion in cash.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.